Alzheimer's Matters Blog

Alzheimer’s Matters, the official blog of the ADDF, features insights, perspectives and commentary on current topics of interest in Alzheimer’s disease and related drug discovery.

Alzheimer’s Disease: An Unrecognized Killer


We’ve known for years that the number of deaths caused by Alzheimer’s disease and related dementias have been underreported, but a recent study identified the disease as the potential third-leading cause of death in the U.S. after heart disease and cancer. The study, published last week in the journal Neurology, found that the number of people who die from Alzheimer’s may be five times higher than previously thought, partly because death certificates often fail to list Alzheimer’s as a contributing cause of death. But this is only part of the story. The problems begin many years before death, when the disease is in its earliest stages.

2013 ADDF Year in Review


2013 was filled with many accomplishments and forward movement in the field of Alzheimer’s research, thanks in part to your ongoing support and generosity. This year, as we celebrate ADDF’s 10th anniversary, we look forward to working together to advance the most promising Alzheimer’s research and ultimately impact the lives of millions around the world.

Balancing Individual Patients And Society Under Healthcare Reform: The Case of Amyvid


An 80-year-old successful and active businessman came to see me because of mild memory problems, and was afraid he had early Alzheimer's disease. Before he stepped into my office he'd already been considering major life-altering questions such as "Do I now need to quit the lifelong work that I love?," "how soon will I be disabled and demented?," and "how will my family take care of me if I have Alzheimer's?"

The Key to Fighting Alzheimer’s Costs: Drug Discovery


The current and projected costs of dementia care are enormous, costing the US as much as heart disease or cancer today, and creating a potentially crippling financial burden on our society in the future, as the number of people diagnosed with dementia is expected to more than double in the next 30 years.